SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001615774-18-000031
Filing Date
2018-01-03
Accepted
2018-01-03 06:05:24
Documents
1
Period of Report
2018-01-02

Document Format Files

Seq Description Document Type Size
1 4 s108608_form4.html 4  
1 4 s108608_form4.xml 4 3344
  Complete submission text file 0001615774-18-000031.txt   4813
Mailing Address 712 FIFTH AVENUE 49TH FLOOR NEW YORK NY 10019
Business Address
RAPP MICHAEL (Reporting) CIK: 0001405685 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37526 | Film No.: 18503283

Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Issuer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations